173 related articles for article (PubMed ID: 8041913)
1. Calculation of benchmark doses from teratology data.
Auton TR
Regul Toxicol Pharmacol; 1994 Apr; 19(2):152-67. PubMed ID: 8041913
[TBL] [Abstract][Full Text] [Related]
2. Quantalization of continuous data for benchmark dose estimation.
Gaylor DW
Regul Toxicol Pharmacol; 1996 Dec; 24(3):246-50. PubMed ID: 8975754
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationship of teratogenicity and prenatal-toxic risk estimation of 6-mercaptopurine riboside in mice.
Platzek T; Bochert G
Teratog Carcinog Mutagen; 1996; 16(3):169-81. PubMed ID: 8983119
[TBL] [Abstract][Full Text] [Related]
4. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
Filipsson AF; Sand S; Nilsson J; Victorin K
Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
[TBL] [Abstract][Full Text] [Related]
5. Procedures for calculating benchmark doses for health risk assessment.
Gaylor D; Ryan L; Krewski D; Zhu Y
Regul Toxicol Pharmacol; 1998 Oct; 28(2):150-64. PubMed ID: 9927564
[TBL] [Abstract][Full Text] [Related]
6. Role of the standard deviation in the estimation of benchmark doses with continuous data.
Gaylor DW; Slikker W
Risk Anal; 2004 Dec; 24(6):1683-7. PubMed ID: 15660621
[TBL] [Abstract][Full Text] [Related]
7. The developmental toxicity of inhaled methanol in the CD-1 mouse, with quantitative dose-response modeling for estimation of benchmark doses.
Rogers JM; Mole ML; Chernoff N; Barbee BD; Turner CI; Logsdon TR; Kavlock RJ
Teratology; 1993 Mar; 47(3):175-88. PubMed ID: 8475461
[TBL] [Abstract][Full Text] [Related]
8. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
Bokkers BG; Slob W
Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
[TBL] [Abstract][Full Text] [Related]
9. A comparison of ratio distributions based on the NOAEL and the benchmark approach for subchronic-to-chronic extrapolation.
Bokkers BG; Slob W
Toxicol Sci; 2005 Jun; 85(2):1033-40. PubMed ID: 15772368
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
11. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
Zhu Y; Wang T; Jelsovsky JZ
Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
13. A statistical evaluation of toxicity study designs for the estimation of the benchmark dose in continuous endpoints.
Slob W; Moerbeek M; Rauniomaa E; Piersma AH
Toxicol Sci; 2005 Mar; 84(1):167-85. PubMed ID: 15483190
[TBL] [Abstract][Full Text] [Related]
14. Precision of benchmark dose estimates for continuous (nonquantal) measurements of toxic effects.
Gaylor DW; Chen JJ
Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):19-23. PubMed ID: 8921542
[TBL] [Abstract][Full Text] [Related]
15. Benchmark Dose Workshop: criteria for use of a benchmark dose to estimate a reference dose.
Barnes DG; Daston GP; Evans JS; Jarabek AM; Kavlock RJ; Kimmel CA; Park C; Spitzer HL
Regul Toxicol Pharmacol; 1995 Apr; 21(2):296-306. PubMed ID: 7644719
[TBL] [Abstract][Full Text] [Related]
16. Calculation of benchmark doses for reproductive and developmental toxicity observed after exposure to isopropanol.
Allen B; Gentry R; Shipp A; Van Landingham C
Regul Toxicol Pharmacol; 1998 Aug; 28(1):38-44. PubMed ID: 9784431
[TBL] [Abstract][Full Text] [Related]
17. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
18. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
Gaylor DW; Swirsky Gold L
Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
[TBL] [Abstract][Full Text] [Related]
19. Background to the ADI/TDI/PTWI.
Herrman JL; Younes M
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
[TBL] [Abstract][Full Text] [Related]
20. A benchmark dose analysis for sodium monofluoroacetate (1080) using dichotomous toxicity data.
Foronda NM; Fowles J; Smith N; Taylor M; Temple W
Regul Toxicol Pharmacol; 2007 Feb; 47(1):84-9. PubMed ID: 16965845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]